Access to timely, high-quality ADHD care has become a growing concern across England. Increased awareness of adult ADHD, alongside long NHS waiting lists, has left many patients unsure how and when they will receive support.
The NHS Right to Choose (RTC) pathway has had a significant and positive impact on ADHD care, offering adults faster access to specialist assessment, diagnosis and treatment, while remaining fully NHS-funded.
This article explains how Right to Choose improves ADHD care, why it matters, and what it means for patients and GPs navigating the current system.
What Is the NHS Right to Choose?
NHS Right to Choose is a legal entitlement in England that allows patients to choose where they receive their first specialist outpatient appointment.
For ADHD care, this means adults can be referred to an NHS-commissioned provider specialising in ADHD, rather than waiting for a local NHS service with lengthy delays.
To use Right to Choose, a patient must:
- be registered with a GP in England
- require their first specialist ADHD assessment
- choose a provider with an NHS Standard Contract
This pathway is not private care, it is delivered within the NHS framework.
Why Right to Choose Has Improved ADHD Care
1. Faster Access to ADHD Assessment
One of the most important benefits of Right to Choose is reduced waiting times.
In many areas, local NHS ADHD services have waiting lists extending into several years. Right to Choose enables patients to access alternative NHS providers with significantly shorter waits, Harrow Health currently has the shortest wait times in the UK, allowing earlier assessment and intervention.
Earlier access to care can:
- reduce emotional distress and burnout
- prevent worsening anxiety or depression
- support stability at work, university or home
2. Greater Access to ADHD Specialists
Right to Choose providers often focus specifically on ADHD services. This ensures assessments are carried out by clinicians with specialist expertise in adult ADHD, following structured, evidence-based pathways.
Specialist-led care improves:
- diagnostic accuracy
- identification of co-occurring conditions
- personalised treatment planning
3. More Consistent, NICE-Aligned Assessments
Right to Choose ADHD assessments follow national clinical guidance, including NICE recommendations. Patients benefit from clear, structured assessments that include:
- detailed clinical interviews
- validated ADHD questionnaires
- assessment of functional impact
- screening for co-existing mental health conditions
This consistency improves patient confidence and understanding of their diagnosis.
The Positive Impact on ADHD Treatment Pathways
Earlier Medication Initiation and Titration
For patients diagnosed with ADHD, Right to Choose providers can initiate medication where clinically appropriate, often without the long delays seen in some traditional pathways. Here are Harrow Health we can prescribe same day.
Medication titration is monitored carefully to:
- find the most effective dose
- manage side effects safely
- support long-term symptom control
Earlier treatment can significantly improve quality of life and daily functioning.
Clearer Shared Care Arrangements
Once medication is stabilised, providers typically request shared care with the patient’s GP. This allows:
- ongoing NHS prescriptions via primary care
- continued specialist oversight
- continuity and safety of treatment
Right to Choose has also helped clarify shared care processes, improving communication between specialists and GP practices.
How Right to Choose Benefits GPs and the NHS
Right to Choose supports the wider NHS by redistributing demand rather than concentrating it within overstretched local services.
For GPs, it provides:
- a clear, structured referral option for ADHD
- reassurance for patients facing long waits
- access to specialist reports and treatment plans
For the NHS overall, it helps manage capacity while maintaining patient choice and clinical standards.
Addressing Common Concerns About Right to Choose
Does Right to Choose reduce the quality of ADHD care?
No. Providers must meet NHS contractual standards and follow national guidance.
Is Right to Choose the same as private care?
No. It is an NHS-funded pathway for eligible patients.
Does it negatively affect local NHS services?
No. It offers patients an alternative route while supporting system capacity.
Why Right to Choose Matters for ADHD Care
ADHD is a lifelong neurodevelopmental condition that can affect education, employment, relationships and mental wellbeing. Delays in assessment and treatment can have lasting consequences.
Right to Choose has had a positive impact by:
- reducing barriers to diagnosis
- improving access to specialist-led care
- supporting earlier, evidence-based treatment
- empowering patients with informed choice
Want to Learn More About ADHD and Right to Choose?
Understanding your options is an important step towards accessing timely ADHD care.
- If you are a patient and would like to learn more about the NHS Right to Choose pathway for ADHD, including what to expect and how to speak to your GP, you can find out more here:
👉 https://adhdrighttochoose.com/information-for-patients/ - If you are a GP looking to refer a patient for an ADHD assessment under NHS Right to Choose, with clear guidance on the referral process, please click here:
👉 https://adhdrighttochoose.com/information-for-gps/
